Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:05 PM
Ignite Modification Date:
2025-12-24 @ 5:05 PM
NCT ID:
NCT05734950
Eligibility Criteria:
Inclusion Criteria:
* Post-menopausal women aged \>70 years at the time of diagnosis of invasive breast cancer.
* ER positive (Allred score \>5/8), HER2 negative early invasive BC.
* Stage I-III BC.
* Surgical tissue available.
* No pre-surgical systemic therapy (i.e., no pre-operative ET or chemotherapy).
* Planned adjuvant ET with an aromatase-inhibitor.
* No adjuvant chemotherapy.
* Surgery was performed between 1st January 2014 and 31st December 2016.
Exclusion Criteria:
* Pre- or perimenopausal.
* ER negative or HER2-positive BC.
* Multifocal cancer where not all of foci ER positive HER2 negative
* Bilateral breast cancer.
* Stage IV breast cancer.
* Benign histology or DCIS.
* Pre-surgical treatment.
* Prior chemotherapy for BC.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
71 Years
Study:
NCT05734950
Study Brief:
Protocol Section:
NCT05734950